These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 43806)

  • 1. The pharmacokinetics and biotransformation of the new benzodiazepine lormetazepam in humans. I. Absorption, distribution, elimination and metabolism of lormetazepam-5-14C.
    Hümpel M; Illi V; Milius W; Wendt H; Kurowski M
    Eur J Drug Metab Pharmacokinet; 1979; 4(4):237-43. PubMed ID: 43806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics and biotransformation of lormetazepam. II. Radioimmunologic determinations in plasma and urine of young and elderly subjects: first-pass effect.
    Hümpel M; Nieuweboer B; Milius W; Hanke H; Wendt H
    Clin Pharmacol Ther; 1980 Nov; 28(5):673-9. PubMed ID: 6108174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and biotransformation of the new benzodiazepine, lormetazepam, in man. III. Repeated administration and transfer to neonates via breast milk.
    Hümpel M; Stoppelli I; Milia S; Rainer E
    Eur J Clin Pharmacol; 1982; 21(5):421-5. PubMed ID: 6122580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal biliary excretion and enterohepatic recirculation of lormetazepam in man as investigated by a new nasobiliary drainage technique.
    Hellstern A; Hildebrand M; Hümpel M; Hellenbrecht D; Saller R; Madetzki C
    Int J Clin Pharmacol Ther Toxicol; 1990 Jun; 28(6):256-61. PubMed ID: 1973917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of lorazepam. I. Absorption and disposition of oral 14C-lorazepam.
    Greenblatt DJ; Schillings RT; Kyriakopoulos AA; Shader RI; Sisenwine SF; Knowles JA; Ruelius HW
    Clin Pharmacol Ther; 1976 Sep; 20(3):329-41. PubMed ID: 8232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels and urinary excretion of lormetazepam in patients with liver cirrhosis and in healthy volunteers.
    Hildebrand M; Hellstern A; Hümpel M; Hellenbrecht D; Saller R
    Eur J Drug Metab Pharmacokinet; 1990; 15(1):19-26. PubMed ID: 1974495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lormetazepam--plasma concentrations in volunteers following sublingual and oral dosing.
    Luscombe DK
    Psychopharmacology Suppl; 1984; 1():99-104. PubMed ID: 6147846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pharmacokinetics of lormetazepam following cimetidine].
    Doenicke A; Dorow R; Täuber U
    Anaesthesist; 1991 Dec; 40(12):675-9. PubMed ID: 1685875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative bioavailability in humans for oral tablets and solutions of lormetazepam.
    Zecca L; Reina L; Scaglione F; Ferrario P; Pirola R; Ceccarelli G; Ciampini M; Fraschini F
    Arzneimittelforschung; 1985; 35(12):1870-2. PubMed ID: 2869762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening, detection and biotransformation of lormetazepam, a new hypnotic agent from the 1,4-benzodiazepine series (author's transl)].
    Schütz H; Fitz H
    Arzneimittelforschung; 1982; 32(3):177-83. PubMed ID: 6123328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and biotransformation of the new benzodiazepine, lormetazepam, in man. III. Repeated administration and transfer to neonates via breast milk.
    Seyberth HW
    Eur J Clin Pharmacol; 1983; 24(1):139-40. PubMed ID: 6131824
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical pharmacokinetics of lorazepam: a review.
    Kyriakopoulos AA; Greenblatt DJ; Shader RI
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):16-23. PubMed ID: 30762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of uremia and hemodialysis on lormetazepam disposition.
    Kampf D; Huempel M; Lerche U; Kessel M
    Clin Pharmacol Ther; 1981 Jul; 30(1):77-85. PubMed ID: 6113073
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative metabolism of lorazepam in man and four animal species.
    Ruelius HW
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):11-5. PubMed ID: 30761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lorazepam: glucuronide formation in the cat.
    Schillings RT; Sisenwine SF; Schwartz MH; Ruelius HW
    Drug Metab Dispos; 1975; 3(2):85-8. PubMed ID: 236163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic correlates of modified absorption: studies with lormetazepam.
    Pierce DM; Franklin RA; Harry TV; Nicholson AN
    Br J Clin Pharmacol; 1984 Jul; 18(1):31-5. PubMed ID: 6146348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The disposition and metabolism of a hypnotic benzodiazepine, quazepam, in the hamster and mouse.
    Hilbert J; Pramanik B; Symchowicz S; Zampaglione N
    Drug Metab Dispos; 1984; 12(4):452-9. PubMed ID: 6148212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of lorazepam. II. Intramuscular injection.
    Greenblatt DJ; Joyce TH; Comer WH; Knowles JA; Shader RI; Kyriakopoulos AA; MacLaughlin DS; Ruelius HW
    Clin Pharmacol Ther; 1977 Feb; 21(2):222-30. PubMed ID: 13960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The absorption, distribution and excretion of [14C]lormetazepam in dogs, rabbits, rats and rhesus monkeys.
    Girkin R; Baldock GA; Chasseaud LF; Hümpel M; Hawkins DR; Mayo BC
    Xenobiotica; 1980 Jun; 10(6):401-11. PubMed ID: 6106319
    [No Abstract]   [Full Text] [Related]  

  • 20. Flunitrazepam and lormetazepam do not affect the pharmacokinetics of the benzodiazepine antagonist Ro 15-1788.
    Klotz U; Duka T; Dorow R; Doenicke A
    Br J Clin Pharmacol; 1985 Jan; 19(1):95-8. PubMed ID: 3919752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.